Int J Ophthalmol. 2025 Jan 18;18(1):39-50.doi: 10.18240/ijo.2025.01.05. eCollection 2025. HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia HMGB2敲除通过抑制视网膜缺血后NLRP3炎性体活化改善视网膜神经节细胞损伤
Oncol Res. 2025 Jan 16;33(2):369-380.doi: 10.32604/or.2024.046774. eCollection 2025. Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1 Circ-PAN3通过海绵状miR-153和上调细胞周期蛋白D1促进肝细胞癌的生长
BMC Cancer. 2025 Jan 14;25(1):84.doi: 10.1186/s12885-025-13464-x. CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma CircCCT2/miR-146a-5p/IRAK1轴促进头颈部鳞状细胞癌的发展
Cancer Cell Int. 2025 Jan 13;25(1):10.doi: 10.1186/s12935-025-03638-9.Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation (IF:5.3).异质性核核糖核蛋白C通过增强XB130mRNA的稳定性和翻译促进非小细胞肺癌的进展
Biochim Biophys Acta Mol Basis Dis. 2025 Jan;1871(1):167498.doi: 10.1016/j.bbadis.2024.167498. Epub 2024 Sep 5. S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia S100A4通过GP130/JAK2/STAT3信号传导介导急性髓系白血病髓系抑制细胞的积累和功能 (IF:6.633).
Mol Neurobiol. 2025 Nov 21;63(1):120.doi: 10.1007/s12035-025-05356-9. Fluvoxamine Attenuates Blood-Brain Barrier Disruption in Drug-Resistance Epilepsy and inhibits Ferroptosis via the Sigma-1 Receptor-TAMM41 signaling in bEnd.3 cells 氟伏沙明可减轻耐药性癫痫中的血脑屏障破坏，并通过Sigma-1受体-TAMM41信号通路抑制bEnd.3细胞中的铁死亡
Adv Sci (Weinh). 2024 Dec 24:e2411210.doi: 10.1002/advs.202411210. Enzyme-Responsive Nanoparachute for Targeted miRNA Delivery: A Protective Strategy Against Acute Liver and Kidney Injury 靶向miRNA递送的酶应答纳米：一种针对急性肝肾损伤的保护策略(IF:14.3).
Cardiovasc Diabetol. 2024 Dec 21;23(1):452.doi: 10.1186/s12933-024-02545-z. ANXA1-FPR2 axis mitigates the susceptibility to atrial fibrillation in obesity via rescuing AMPK activity in response to lipid overload ANXA1-FPR2轴通过拯救AMPK活性以应对脂质超载来减轻肥胖患者对房颤的易感性 (IF:8.57).
Front Pharmacol. 2024 Dec 18:15:1464852.doi: 10.3389/fphar.2024.1464852. eCollection 2024. Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC 转录因子MEF2D调节ACSL3的异常表达，并通过抑制肝细胞癌中的铁下垂来增强索拉非尼的耐药性 (IF:5.6).
Mol Med Rep. 2025 Feb;31(2):31.doi: 10.3892/mmr.2024.13397. Epub 2024 Nov 22. MDM2 interacts with PTEN to inhibit endothelial cell development and promote deep vein thrombosis via the JAK/STAT signaling pathway MDM2与PTEN相互作用，通过JAK/STAT信号通路抑制内皮细胞发育并促进深静脉血栓形成
